Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

United Therapeutics (UTHR) Times Interest Earned (2016 - 2026)

United Therapeutics' Times Interest Earned history spans 17 years, with the latest figure at $115.06 for Q4 2025.

  • On a quarterly basis, Times Interest Earned rose 154.13% to $115.06 in Q4 2025 year-over-year; TTM through Dec 2025 was $76.54, a 138.45% increase, with the full-year FY2025 number at $76.54, up 138.45% from a year prior.
  • Times Interest Earned hit $115.06 in Q4 2025 for United Therapeutics, down from $129.5 in the prior quarter.
  • Over the last five years, Times Interest Earned for UTHR hit a ceiling of $129.5 in Q3 2025 and a floor of -$14.09 in Q1 2021.
  • Historically, Times Interest Earned has averaged $41.61 across 5 years, with a median of $34.07 in 2022.
  • Biggest five-year swings in Times Interest Earned: crashed 169.29% in 2021 and later surged 534.99% in 2022.
  • Tracing UTHR's Times Interest Earned over 5 years: stood at $36.13 in 2021, then tumbled by 60.48% to $14.28 in 2022, then increased by 20.65% to $17.23 in 2023, then skyrocketed by 162.86% to $45.28 in 2024, then soared by 154.13% to $115.06 in 2025.
  • Business Quant data shows Times Interest Earned for UTHR at $115.06 in Q4 2025, $129.5 in Q3 2025, and $49.93 in Q2 2025.